A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression
- PMID: 16945906
- PMCID: PMC1557799
- DOI: 10.1073/pnas.0606179103
A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression
Abstract
RNAi is proving to be a powerful experimental tool for the functional annotation of mammalian genomes. The full potential of this technology will be realized through development of approaches permitting regulated manipulation of endogenous gene expression with coordinated reexpression of exogenous transgenes. We describe the development of a lentiviral vector platform, pSLIK (single lentivector for inducible knockdown), which permits tetracycline-regulated expression of microRNA-like short hairpin RNAs from a single viral infection of any naïve cell system. In mouse embryonic fibroblasts, the pSLIK platform was used to conditionally deplete the expression of the heterotrimeric G proteins Galpha12 and Galpha13 both singly and in combination, demonstrating the Galpha13 dependence of serum response element-mediated transcription. In RAW264.7 macrophages, regulated knockdown of Gbeta2 correlated with a reduced Ca(2+) response to C5a. Insertion of a GFP transgene upstream of the Gbeta2 microRNA-like short hairpin RNA allowed concomitant reexpression of a heterologous mRNA during tetracycline-dependent target gene knockdown, significantly enhancing the experimental applicability of the pSLIK system.
Conflict of interest statement
Conflict of interest statement: No conflicts declared.
Figures




Similar articles
-
Sustained knockdown of a disease-causing gene in patient-specific induced pluripotent stem cells using lentiviral vector-based gene therapy.Stem Cells Transl Med. 2013 Sep;2(9):641-54. doi: 10.5966/sctm.2013-0017. Epub 2013 Aug 7. Stem Cells Transl Med. 2013. PMID: 23926210 Free PMC article.
-
Lentiviral vector system for coordinated constitutive and drug controlled tetracycline-regulated gene co-expression.Biomaterials. 2015 Sep;63:189-201. doi: 10.1016/j.biomaterials.2015.06.022. Epub 2015 Jun 16. Biomaterials. 2015. PMID: 26113075
-
Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study.BMC Biotechnol. 2007 Jul 16;7:41. doi: 10.1186/1472-6750-7-41. BMC Biotechnol. 2007. PMID: 17634114 Free PMC article.
-
Strategies for targeting lentiviral vectors.Curr Gene Ther. 2008 Dec;8(6):449-60. doi: 10.2174/156652308786848003. Curr Gene Ther. 2008. PMID: 19075628 Review.
-
The retroviral vector family: something for everyone.Virus Genes. 2017 Oct;53(5):714-722. doi: 10.1007/s11262-017-1489-0. Epub 2017 Jul 31. Virus Genes. 2017. PMID: 28762206 Review.
Cited by
-
β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1.Mol Cancer Res. 2020 Dec;18(12):1839-1848. doi: 10.1158/1541-7786.MCR-19-1037. Epub 2020 Sep 14. Mol Cancer Res. 2020. PMID: 32928910 Free PMC article.
-
α-Synuclein overexpression represses 14-3-3θ transcription.J Mol Neurosci. 2013 Nov;51(3):1000-9. doi: 10.1007/s12031-013-0086-5. Epub 2013 Aug 4. J Mol Neurosci. 2013. PMID: 23912650 Free PMC article.
-
The obesity-induced transcriptional regulator TRIP-Br2 mediates visceral fat endoplasmic reticulum stress-induced inflammation.Nat Commun. 2016 Apr 25;7:11378. doi: 10.1038/ncomms11378. Nat Commun. 2016. PMID: 27109496 Free PMC article.
-
FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells.Biochem Biophys Res Commun. 2010 Nov 5;402(1):129-34. doi: 10.1016/j.bbrc.2010.09.129. Epub 2010 Oct 8. Biochem Biophys Res Commun. 2010. PMID: 20933505 Free PMC article.
-
A piggyBac-based toolkit for inducible genome editing in mammalian cells.RNA. 2019 Aug;25(8):1047-1058. doi: 10.1261/rna.068932.118. Epub 2019 May 17. RNA. 2019. PMID: 31101683 Free PMC article.
References
-
- Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Nature. 2001;411:494–498. - PubMed
-
- Hannon GJ, Rossi JJ. Nature. 2004;431:371–378. - PubMed
-
- Brummelkamp TR, Bernards R, Agami R. Science. 2002;296:550–553. - PubMed
-
- Paul CP, Good PD, Winer I, Engelke DR. Nat Biotechnol. 2002;20:505–508. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous